Blastomycosis is an infection caused by the thermally dimorphic fungus Blastomyces dermatitidis. The disease occurs most commonly in North America along the Ohio and Mississippi River valleys, in southeastern states, and around the Great Lakes [1] . Sporadic cases have been reported in Central and South America, Europe, India, the Middle East, and Africa [2] [3] [4] .
Blastomycosis is a significant public health problem in Wisconsin, where it is a reportable disease in humans [5] [6] [7] [8] [9] . Data collected by the Wisconsin Division of Health and Family Services from 2000 to 2006 indicate that incidences of infection as high as 10.4-41.9/ 100 000 have been observed in several north-central counties [10] .
The symptoms of blastomycosis range from asymptomatic infection to fulminant respiratory failure with acute respiratory distress syndrome and dissemination of infection to bone, skin, central nervous system, and other organs. Clinicians treating this disease often cannot predict which patients will have favorable outcomes and those who will experience severe manifestations, including death. Although host factors, comorbidities, amount of inoculum, and other variables can influence presentation and outcome for many infectious diseases, it is well established that genetic variation among strains of an infecting agent can modulate virulence and have a profound influence on outcome [11] [12] [13] [14] . Thus, genetic variability of a pathogen could be an important predictor of clinical outcome and potentially inform treatment options for individual patients.
We recently used microsatellite typing to examine the population-level genetic structure of a large group of clinical and environmental isolates of B. dermatitidis. Two predominant genetic groups were observed: a highly monomorphic group (group 1) and a highly polymorphic group (group 2) [15] . Given the variation of symptoms clinically observed in blastomycosis patients and the genetic variability of the organism shown previously [15] , we aimed to determine whether clinical phenotype and outcomes vary based on genetic group of the infecting organism. In addition, a subgroup of the isolates was genotyped and assigned to genetic groups using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and compared to the group assignments generated by microsatellite typing.
METHODS

Isolate Sources
Marshfield Labs serves more than 500 healthcare facilities and 3000 veterinary practices located in endemic areas for blastomycosis in northern Wisconsin. All isolates of B. dermatitidis used in this study were recovered in the mycology section of Marshfield Labs from 1999 to 2009 and stored frozen (−20°C) at the Marshfield Clinic Research Foundation. All isolates were obtained as part of clinical diagnosis and identified as B. dermatitidis using standard methods, which included culture of the mold form on brain-heart infusion agar with blood at 25°C and conversion to the characteristic yeast form when incubated in Middlebrook 7H9 broth at 35°C. DNA Extraction, Microsatellite Typing, and Cluster Analysis DNA was extracted from frozen isolates using a QIAamp DNA mini kit and tissue protocol (QIAGEN), with modifications according to Meece et al [16] . For genetic typing of each isolate, 27 polymorphic microsatellite loci were evaluated as previously described [15] . Briefly, for each locus, 2 µL of extracted DNA was amplified by PCR with a HotStar Taq master mix kit (QIAGEN), according to the manufacturer's recommendations, with a 0.2-µM final concentration of primers. Amplified products were sized on an ABI 3130xl genetic analyzer (Applied Biosystems) using GeneScan-500 ROX size standard (Applied Biosystems) in Hi-Di formamide (Applied Biosystems). DNA fragment sizes were manually grouped into their appropriate alleles using the fixed-bin method [17] .
The following 3 methods were used to predict the most likely number of genetic groups present in the microsatellite data and to assign membership of each isolate: genetic distance-neighbor joining clustering, Bayesian admixture, and principle coordinate analysis (PCoA). Haplotypes were ascertained by identifying matching samples using Genetic Analysis in Excel v6.41 [18] . To minimize the effects of including multiple representatives of the same genotype (ie, haplotypes) in genetic clustering efforts, all genetically identical isolates were subsumed to a single unique haplotype. Isolates differing at 1 or more loci were considered unique. Following haplotype construction, genetic structure among the samples was first estimated by constructing an unrooted neighbor-joining tree of unique haplotypes based on an allele sharing distance in PowerMarker v3 [19] [20] [21] [22] . Confidence in the resolved topology was based on 1000 bootstrap pseudoreplicates across loci. Next, the Bayesian approach of the program STRUCTURE [23] was used to predict the minimum number of genetic units or clusters within the composite data. Analysis settings included: K (the putative number of genetic groups) ranging from 1 to 12, the use of the admixture model, correlated allele frequencies between populations, and lambda = 1. The degree of admixture (alpha) was inferred from the data as advised in the software's manual. Five iterations of each K were performed, each consisting of a burn-in of 100 000 cycles, followed by 100 000 repetitions. The method of Evanno et al [24] , as estimated using Structure Harvester [25] , was used to assess the most likely K given the data in conjunction with the mean and variance of the ln probability of K. The last analysis of genetic structure was a PCoA of the standardized covariance of the haplotypic genetic distance, as performed in Genetic Analysis in Excel v6.41. The first and second principle coordinates were plotted to graphically illustrate clusters of haplotypes.
PCR-RFLP Typing and Method Comparison
Twenty-five percent of the isolates in this study (n = 56) were genotyped using PCR-RFLP, as described by McCullough et al [26] with modifications by Meece et al [16] . The genotyping group assignments from PCR-RFLP and microsatellite typing were then compared.
Medical Record Data Abstraction
For each B. dermatitidis isolate, patient demographic information and clinical disease characteristics were abstracted from the corresponding patient's medical record according to a Marshfield Clinic Research Foundation Institutional Review Board-approved protocol. Medical record abstraction was conducted independently from genotyping at a separate phase of the study. For Marshfield Clinic patients, data were abstracted from each patient's electronic health record. For patients not part of the Marshfield Clinic system, similar data were obtained from state-reportable disease forms and an extensive, standardized questionnaire administered by the Wisconsin Division of Public Health. The clinical disease characteristics collected for each patient included the following: cough, hemoptysis, poor appetite, weight loss, joint pain, headache, back pain, chest pain, bone pain, fractures, fever, chills, night sweats, fatigue, muscle pain, location of infection, dissemination site, time from disease onset to diagnosis, hospitalization/ duration, antifungal therapy/dosage/duration of treatment, and death. Patient demographic information collected included the following: age at diagnosis, race, gender, smoking status/packs per day, and comorbid conditions.
Association Analysis
Upon completion of phylogenetic analysis and genetic group assignment, this information was combined with medical record abstraction data for univariate and multivariate analysis. Univariate analyses, odds ratios, and corresponding 95% confidence intervals were calculated for the association between each potential risk factor and genetic types using unconditional logistic regression modeling with α = 0.05. In addition, multivariate stepwise logistic regression modeling using the risk factors that showed statistically significant results by univariate analysis was used to identify sets of important predictors for the status of genetic type. All data analyses were carried out using SAS v9.2 (SAS).
RESULTS
Microsatellite Typing and Cluster Analysis
A total of 227 clinical B. dermatitidis isolates, consisting of 132 unique haplotypes, were analyzed for phylogenetic relationships. Assembly of an unrooted neighbor-joining tree showed 2 main genetic groups separated by a deep node bootstrapped at 99% (Figure 1 ). STRUCTURE analysis of the unique haplotypes supported 2 genetic units in the data (K = 2) based on the method of Evanno et al [24] and the linearity and variance of lnP(D). The individual ancestry of each haplotype based on K = 2 showed 129 haplotypes with a majority q value >80% ( Figure 2 ). Principal coordinate analysis ( Figure 3) showed clustering of the haplotypes into 2 primary groups. The first primary axis (coordinate 1) explained a majority of the variance (51%) and differentiated group 1 from group 2. The secondary axis (coordinate 2) explained another 18% of variance. Group membership assignment for each isolate was 100% concordant across all 3 analysis methods, with group 1 containing 34 haplotypes representing 128 isolates (56%) and group 2 containing 98 haplotypes representing 99 isolates (44%). Three isolates (monotypic haplotypes H47, H70, and H126) had a majority assignment in group 2 by STRUCTURE at <80% genetic membership threshold (q value). The evidence from all 3 analysis methods showed consistent support for membership of these 3 isolates (haplotypes H47, H70, and H126 identified in Figures 1-3 ) in group 2, and the 3 were subsequently placed in that group for the purposes of this study.
PCR-RFLP Typing and Method Comparison
Of the 56 isolates genotyped using PCR-RFLP, 34 were classified as group A, 21 were group B, and 1 group C. Comparison of PCR-RFLP groups with microsatellite groups for these 56 isolates revealed that all 34 PCR-RFLP group A isolates were group 1 isolates by microsatellite typing. In contrast, all isolates in PCR-RFLP groups B and C belonged to group 2 by microsatellite analysis.
Patient Demographics and Clinical Disease Characteristics
The Marshfield Clinic electronic health record was the source of information for 123 cases, public health reportable disease worksheets and questionnaires for 50 cases, and a combination of both for 54 cases. The age range of patients was 3-91 years (mean 43.4), with 28 (12%) patients being age 18 years or younger at diagnosis. Gender, race/ethnicity, smoking status, and comorbidities of patients are shown in Table 1 . Ninety-two patients (41%) were identified as having 1 or more comorbid condition(s). Clinical disease characteristics and patient antifungal treatments are shown in Table 2 . Disseminated disease was reported in 43/227 (19%) of cases, with 9 patients (4% of total cases, or 21% of disseminated disease cases) having multiple sites of dissemination ( Table 2 ). The time from onset of symptoms to diagnosis for each case was based on patient self-reporting of initiation of blastomycosis symptoms and ranged from <1 to 48 months. The majority of patients (n = 154, 68%) were diagnosed with blastomycosis within 1 month of onset of symptoms. One hundred and thirty-four cases (59%) required hospitalization. Duration of hospitalization ranged from 1 to 134 days. Twenty-one cases (9%) resulted in death, of which 15 (71%) were pulmonaryonly disease, 5 disseminated (24%), and 1 unspecified. Locations of infection in the 5 cases of disseminated disease that resulted in death were as follows: deep tissue abscess (n = 1), skin (n = 1), and both skin and bone (n = 3). The age range for fatal cases was 8-91 years (mean 61). Thirteen (62%) of the fatal cases were male, and 17 (81%) had an underlying medical condition.
Association Analysis
Univariate analysis demonstrated 10 clinical disease characteristics and 6 patient demographics (including comorbid conditions) as having statistically significant associations with a particular genetic group of B. dermatitidis (Table 3 ). In summary, infection caused by group 1 isolates was more likely to be associated with pulmonary-only infections and constitutional symptoms such as fever, night sweats, cough, fatigue, poor appetite, chills, and chest pain. In contrast, genetic group 2 strains were more likely to disseminate to other tissues, especially skin. Patients infected with isolates from group 2 were more likely to have a comorbid condition, be current smokers, and be older in age.
In multivariate analysis, 3 of the 16 clinical characteristics and patient demographics identified as important in the univariate analysis maintained significant predictors for infection with genetic group 2 organisms (Table 4) .
DISCUSSION
To our knowledge, the results of this study provide the first evidence that genetic variation in B. dermatitidis may be associated with differences in patient demographics and clinical disease characteristics of infection. Although our cohort of patients was roughly divided between those infected with group 1 (n = 128) and group 2 (n = 99) strains, there were significant differences in important clinical variables between the 2 groups. Patients infected with group 1 strains were more likely to report constitutional symptoms such as fever, night sweats, and chest pain and be diagnosed 6 weeks or less from onset of symptoms. In contrast, patients infected with group 2 isolates were more likely to be diagnosed later, exhibit disseminated disease, have comorbid conditions, and be current smokers. Hospitalization (P = .0565) and mean hospital duration, in days (P = .1460), were not associated with a particular genetic group. Our study cohort had a relatively small number of deaths (n = 21, 9%), which were almost equally caused by group 1 (n = 11) and group 2 (n = 10) infections (P = .8180). Notably, 15 of the 21 deaths (71%) resulted from a pulmonary-only infection. A larger study would be necessary to achieve sufficient statistical power to determine whether or not mortality rates differ significantly between the 2 groups of organisms.
Previous studies have shown that certain ethnic groups such as Asians (especially Pacific Islander and Filipino), Hispanics, and African Americans are more likely to experience Figure 1 . Unrooted neighbor-joining tree of allele sharing distances for all 132 haplotypes. Black dots correspond to group 1 (showing 34 haplotypes representing 128 isolates) and gray diamonds to group 2 (showing 98 haplotypes representing 99 isolates) from the PCoA and STRUCTURE output (see Figures 3 and 4) . Node support represents percent resolution of node across 1000 bootstrap pseudoreplicates. Stars represent branches leading to group 2 individuals (H47, H70, and H126) that show mean majority q values < 80% in STRUCTURE analysis. disseminated disease with the closely related dimorphic fungus, Coccidioides immitis/posadasii, [27] [28] [29] [30] . In our study, white patients, compared to nonwhite patients, were significantly more likely to be infected with group 2 strains of B.
dermatitidis, which are associated with disseminated disease, ( Table 3) . Although we could not evaluate nonwhite minority groups separately due to small sample sizes, we did find that 11 of 13 (85%) strains infecting American Indian patients, 7 of 9 (78%) infecting Asian patients, and 3 of 4 (75%) infecting Hispanic patients were group 1 organisms. In addition, 25 of 27 (93%) blastomycosis cases in nonwhites manifested as pulmonary-only infections. This suggests that patient genetic background may influence host susceptibility and immune response to different B. dermatitidis strains and warrants further investigation. A significant observation was the apparent association of group 2 infections with comorbid conditions and increased rate of dissemination compared with group 1 infections. For example, of 41 patients in group 1 with comorbid conditions, 3 (7%) had disseminated disease, whereas of the 51 patients in group 2 with comorbid conditions, 14 (27%) had disseminated disease. Although it is possible that the increased rate of dissemination observed with group 2 strains was due, at least in part, to impaired host immunity associated with comorbidities, our findings suggest that genetic group of the infecting strain also plays some role in modulating dissemination. A practical limitation of our study was that because of small numbers, all comorbidities were combined in order to obtain statistical power for evaluating association with a specific genetic group. Therefore, conditions such as human immunodeficiency virus infection and steroid therapy, which more profoundly affect host immune function, were not considered separately or weighted as a more serious comorbid condition. Although mathematically we have shown an association between group 2 strains of B. dermatitidis and disseminated disease, causality has not yet been established.
Comparison of phenotypic traits between group 1 and group 2 strains could provide insight into the epidemiology of blastomycosis. For example, genetic analysis of clinical isolates associated with 2 recent Wisconsin outbreaks (Lincoln County, 2006, of which 9 samples are included in this current study [6] , and Marathon County, 2009-2010, unpublished data) revealed that both outbreaks were due to group 1 strains. Additionally, retrospective analysis of clinical and environmental isolates obtained from earlier outbreaks in Wisconsin near Eagle River (Vilas County), the Tomorrow River (Portage County) [31] , and the Crystal River (Waupaca County) [32] again showed only group 1 strains. This apparent overrepresentation of group 1 strains with outbreaks could be due to phenotypic traits associated with increased transmission of infections to humans. These could include, but are not limited to, increased spore formation by certain strains of B. dermatitidis and the ability to occupy specific ecologic niches that overlap with human activity.
The molecular basis for differences in clinical phenotype observed between the 2 genetic groups is not known. One possibility is that significant differences in the presence and/or expression of virulence factors may exist between the 2 genetic groups. Previous studies have documented the central role that 
a Some patients reported dissemination to more than 1 extrapulmonary site b Some patients were treated with multiple antifungal drug therapies. BAD1 plays as a potent virulence factor in B. dermatitidis infections. BAD1 is an adhesin expressed on the surface of the yeast form of B. dermatitidis; however, it is absent in the mold form. It promotes lung infection by fixing yeast cells to pulmonary tissue, including macrophages [33] . Additionally, BAD1 expression is associated with other pathogenic mechanisms that alter host immunity, including suppression of tumor necrosis factor-α, induction of transforming growth factor-β, and siderophore-like action in binding calcium [34] [35] [36] .
Further investigation of differences between BAD1 and other virulence factor expression between the genetic groups is warranted and could be facilitated by a comparative genomics approach that uses next-generation sequencing technology. Recent investigations of population genetic diversity in B. dermatitidis have incorporated several genotyping techniques. In order to reconcile nomenclature derived from microsatellite genotyping with PCR-RFLP groups, we selected a subgroup of isolates for genetic typing by both methods [26] . Comparison of isolate grouping by both methodologies showed that all PCR-RFLP group A isolates belonged to microsatellite group 1. In contrast, isolates in groups B and C by PCR-RFLP analysis all clustered in microsatellite genetic group 2. These results are consistent with our previous observation that group 1 strains have low allelic diversity, while group 2 strains, as a group, are more genetically diverse.
Our study has several limitations that must be considered. First, the design was retrospective in nature and collection of clinical information relied, in part, on self-reported data. We identified self-reported features that differed significantly between group 1 and group 2 infections. Some clinical difference between the 2 groups may be due, in part, to systematic differences in disease progression by group, which created a longer interval from onset to diagnosis in group 2, thereby introducing possible recall bias. However, because patients in both groups were sufficiently ill to seek treatment for their infection, differences in recall may be minimal. Second, the B. dermatitidis isolates used for analysis were limited to Wisconsin and do not represent the entire geographic range of the organism. It is possible that additional groups of Blastomyces with unique genetic and virulence characteristics are present in other geographic locations. Finally, each case-associated isolate was assigned to genetic group 1 or 2 based on a combination of the following 3 independent genetic analysis approaches: genetic distance-neighbor joining clustering, Bayesian admixture, and PCoA. The use of these 3 methods produced phylogenetic results consistent with a previous study [15] that used different isolates, thereby demonstrating the reproducibility of this approach. The results of group assignment were consistent across all 3 methods; group assignment for an individual isolate did not vary based on the genetic analysis approach that was used. We concluded that the concordance and statistical support of the 3 analysis methods justified our grouping approach for the association analysis and acknowledge that genetic substructure in the groups, especially group 2, was not taken into account.
Despite these limitations, our results provide a framework with which to further explore the relationship between the genetic diversity in B. dermatitidis and clinical disease in humans and animals. Future research will focus on phenotypic comparison between strains. In addition, clinical implications of polymorphisms in BAD1 will be explored along with whole-genome comparisons to look for additional virulence factors that may vary between the 2 genetic groups. Abbreviations: CI, confidence interval; OR, odds ratio. a Other variables included in the stepwise logistic regression modeling selection were coronary artery disease, chills, chest pain, cough, fatigue, fever, all comorbid conditions, location of infection, night sweats, packs per day, poor appetite, race/ethnicity, and disease onset to diagnosis (≤ or >1 month). b Genetic group 1 is the referent group.
Notes
c CI =95%.
d P value was derived from multivariate logistic regression modeling.
